NCT03583658View on ClinicalTrials.gov

Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

September 2, 2018

Study Completion Date

September 2, 2018

Conditions
Pharyngitis
Interventions
DRUG

ambroxol BIH1526

Pharmaceutical form: lozenges Route of administration: oromucosal

DRUG

placebo

Pharmaceutical form: lozenges Route of administration: oromucosal

Trial Locations (1)

Unknown

Investigational Site Number 7100005, Johannesburg

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT03583658 - Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis | Biotech Hunter | Biotech Hunter